Literature DB >> 2062381

Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution.

J P Wery1, R W Schevitz, D K Clawson, J L Bobbitt, E R Dow, G Gamboa, T Goodson, R B Hermann, R M Kramer, D B McClure.   

Abstract

Phospholipases A2 (PLA2s) may be grouped into distinct families of proteins that catalyse the hydrolysis of the 2-acyl bond of phospholipids and perform a variety of biological functions. The best characterized are the small (relative molecular mass approximately 14,000) calcium-dependent, secretory enzymes of diverse origin, such as pancreatic and venom PLA2s. The structures and functions of several PLA2s are known. Recently, high-resolution crystal structures of complexes of secretory PLA2s with phosphonate phospholipid analogues have provided information about the detailed stereochemistry of transition-state binding, confirming the proposed catalytic mechanism of esterolysis. By contrast, studies on mammalian nonpancreatic secretory PLA2s (s-PLA2s) have only recently begun; s-PLA2s are scarce in normal cells and tissues but large amounts are found in association with local and systemic inflammatory processes and tissue injury in animals and man. Such s-PLAs have been purified from rabbit and rat inflammatory exudate, from synovial fluid from patients with rheumatoid arthritis and from human platelets. Cloning and sequencing shows that the primary structure of the human s-PLA2 has about 37% homology with that of bovine pancreatic PLA2 and 44% homology with that of Crotalus atrox PLA2. The human s-PLA2 is an unusually basic protein, yet contains most of the highly conserved amino-acid residues and sequences characteristic of the PLA2s sequenced so far. Here we report the refined, three-dimensional crystal structure at 2.2 A resolution of recombinant human rheumatoid arthritic synovial fluid PLA2. This may aid the development of potent and specific inhibitors of this enzyme using structure-based design.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062381     DOI: 10.1038/352079a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  30 in total

1.  Total chemical synthesis of enzymatically active human type II secretory phospholipase A2.

Authors:  T M Hackeng; C M Mounier; C Bon; P E Dawson; J H Griffin; S B Kent
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Identification of a specific region of low molecular weight phospholipases A2 (residues 21-40) as a potential target for structure-based design of inhibitors of these enzymes.

Authors:  E Cordella-Miele; L Miele; A B Mukherjee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 3.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

4.  Nonbactericidal secreted phospholipase A2s are potential anti-inflammatory factors in the mammary gland.

Authors:  Eyal Seroussi; Shelly Klompus; Maayan Silanikove; Oleg Krifucks; Fira Shapiro; Arieh Gertler; Gabriel Leitner
Journal:  Immunogenetics       Date:  2013-10-03       Impact factor: 2.846

5.  Phospholipase A2 as a mechanosensor.

Authors:  J Y Lehtonen; P K Kinnunen
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

6.  Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.

Authors:  Caitlin E Cassidy; William N Setzer
Journal:  J Mol Model       Date:  2009-07-15       Impact factor: 1.810

7.  Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue.

Authors:  S Andersen; W Sjursen; A Laegreid; G Volden; B Johansen
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

8.  Selective inhibition of human group IIA-secreted phospholipase A2 (hGIIA) signaling reveals arachidonic acid metabolism is associated with colocalization of hGIIA to vimentin in rheumatoid synoviocytes.

Authors:  Lawrence K Lee; Katherine J Bryant; Romaric Bouveret; Pei-Wen Lei; Anthony P Duff; Stephen J Harrop; Edwin P Huang; Richard P Harvey; Michael H Gelb; Peter P Gray; Paul M Curmi; Anne M Cunningham; W Bret Church; Kieran F Scott
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

9.  Differential inhibition of human secretory and cytosolic phospholipase A2.

Authors:  F Märki; W Breitenstein; E Beriger; R Bernasconi; G Caravatti; J E Francis; R Paioni; H U Wehrli; R Wiederkehr
Journal:  Agents Actions       Date:  1993-03

10.  Topology of the substrate-binding site of a Lys49-phospholipase A2 influences Ca2+-independent membrane-damaging activity.

Authors:  Juliana Martha Sá; Lucimara Chioato; Tatiana Lopes Ferreira; Arthur H C De Oliveira; Roberto Ruller; José César Rosa; Lewis J Greene; Richard J Ward
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.